We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
-2.42%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$11.9B
AUM Growth
-$261M
Cap. Flow
+$174M
Cap. Flow %
1.46%
Top 10 Hldgs %
18.7%
Holding
372
New
5
Increased
150
Reduced
118
Closed
12

Top Sells

Rank Stock Value
1
MAS icon
Masco
MAS
+$54.6M
2
PINC
Premier
PINC
+$48M
3
BLD
TopBuild
BLD
+$17.5M
4
STE icon
Steris
STE
+$14.9M
5
PYPL icon
PayPal
PYPL
+$13.2M

Sector Composition

Rank Sector Weight
1 Technology 21.8%
2 Healthcare 16.07%
3 Financials 14.32%
4 Industrials 14.21%
5 Consumer Discretionary 9.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GE icon
301
GE Aerospace
GE
$374B
$592K 0.01%
6,706
BSX icon
302
Boston Scientific
BSX
$69.5B
$590K ﹤0.01%
11,181
CARR icon
303
Carrier Global
CARR
$51B
$576K ﹤0.01%
10,437
-500
-5% -$27.5K
MCHP icon
304
Microchip Technology
MCHP
$40.3B
$570K ﹤0.01%
7,300
-200
-3% -$16.7K
DFAC icon
305
Dimensional US Core Equity 2 ETF
DFAC
$47.9B
$564K ﹤0.01%
21,537
ALV icon
306
Autoliv
ALV
$9.02B
$562K ﹤0.01%
5,825
-40
-0.7% -$3.83K
ST icon
307
Sensata Technologies
ST
$6.74B
$558K ﹤0.01%
14,741
+1,705
+13% +$68.7K
IBM icon
308
IBM
IBM
$211B
$510K ﹤0.01%
3,637
-100
-3% -$14.2K
QUAL icon
309
iShares MSCI USA Quality Factor ETF
QUAL
$46.4B
$506K ﹤0.01%
3,840
QQQ icon
310
Invesco QQQ Trust
QQQ
$453B
$491K ﹤0.01%
1,371
UL icon
311
Unilever
UL
$137B
$470K ﹤0.01%
8,449
+445
+6% +$25.7K
SHW icon
312
Sherwin-Williams
SHW
$82.7B
$468K ﹤0.01%
1,833
CRM icon
313
Salesforce
CRM
$151B
$467K ﹤0.01%
2,302
VEU icon
314
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
$436K ﹤0.01%
8,411
HCA icon
315
HCA Healthcare
HCA
$87.2B
$435K ﹤0.01%
1,768
PLD icon
316
Prologis
PLD
$135B
$434K ﹤0.01%
3,870
-120
-3% -$14.7K
VT icon
317
Vanguard Total World Stock ETF
VT
$77.1B
$394K ﹤0.01%
4,225
VRTX icon
318
Vertex Pharmaceuticals
VRTX
$121B
$386K ﹤0.01%
1,110
AZN icon
319
AstraZeneca
AZN
$263B
$366K ﹤0.01%
2,700
SCHW
320
Charles Schwab
SCHW
$183B
$361K ﹤0.01%
6,579
NVDA icon
321
NVIDIA
NVDA
$4.86T
$349K ﹤0.01%
8,030
VEA icon
322
Vanguard FTSE Developed Markets ETF
VEA
$229B
$345K ﹤0.01%
7,891
-485
-6% -$22.2K
WAB icon
323
Wabtec
WAB
$49.1B
$345K ﹤0.01%
3,243
VNQ icon
324
Vanguard Real Estate ETF
VNQ
$39.2B
$342K ﹤0.01%
4,522
OTIS icon
325
Otis Worldwide
OTIS
$27.4B
$341K ﹤0.01%
4,248

Similar funds

Boston Trust Walden's Q3 2023 Portfolio in Review

As of Q3 2023, Boston Trust Walden held 372 positions worth $11.9B, down 2.1% from $12.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 4.6%. Boston Trust Walden opened 5 new positions and exited 12, leaving the 372-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

  • Boston Trust Walden's largest Q3 2023 buy was Callon Petroleum Company: 714,242 shares worth $27.9M.
  • Boston Trust Walden added most to Commerce Bancshares in Q3 2023, an estimated $30.6M increase.
  • Boston Trust Walden's biggest Q3 2023 reduction was Masco, cutting an estimated $54.6M.
  • Boston Trust Walden fully exited Premier in Q3 2023, selling an estimated $48M.
  • Boston Trust Walden's ten largest holdings make up 19% of its $11.9B portfolio in Q3 2023.
  • Boston Trust Walden opened 5 new positions and closed 12 in Q3 2023.
  • Boston Trust Walden's portfolio value fell 2.1% quarter-over-quarter to $11.9B.

Based on Boston Trust Walden's 13F filing for Q3 2023, filed 18 Oct 2023.